Stevanato Group S.p.A (STVN) Operating Income (2020 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly Operating Income of $45.3 million for Q1 2026, up 24.39% year-over-year from $36.4 million in Q1 2025, and down 44.48% quarter-over-quarter from $81.6 million in Q4 2025.
Stevanato Group S.p.A (STVN) Operating Income (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Operating Income for 7 consecutive years, with $45.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Income rose 24.39% year-over-year to $45.3 million; the TTM figure through Mar 2026 stood at $235.4 million (up 28.61% YoY), while the FY2025 annual figure was $231.4 million, up 34.42% from the prior year.
- Operating Income slipped to $45.3 million in Q1 2026 per STVN's latest filing, from $81.6 million in the prior quarter.
- Across five years, Operating Income topped out at $81.6 million in Q4 2025 and bottomed at $27.5 million in Q1 2024.
- Historically, Operating Income has averaged $50.9 million across 5 years, with a median of $46.8 million in 2025.
- Annual changes were most pronounced in 2024 — Operating Income tumbled 38.28% — and 2025, when it surged 55.3%.
- Stevanato Group S.p.A's Operating Income stood at $64.4 million in 2022, then grew by 6.96% to $68.9 million in 2023, then advanced by 3.66% to $71.4 million in 2024, then rose by 14.31% to $81.6 million in 2025, then plunged by 44.48% to $45.3 million in 2026.
- Business Quant data shows STVN's Operating Income at $45.3 million in Q1 2026, $81.6 million in Q4 2025, and $61.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 971.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 663.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 11.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 448.71 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 395.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 179.10 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 181.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -31.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 217.00 Mn |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn | 45.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.39 Mn |
| Mar 31, 2026 | 45.31 Mn |
| Dec 31, 2025 | 81.60 Mn |
| Sep 30, 2025 | 61.63 Mn |
| Jun 30, 2025 | 46.83 Mn |
| Mar 31, 2025 | 36.42 Mn |
| Dec 31, 2024 | 71.38 Mn |
| Sep 30, 2024 | 45.06 Mn |
| Jun 30, 2024 | 30.15 Mn |
| Mar 31, 2024 | 27.47 Mn |
| Dec 31, 2023 | 68.86 Mn |
| Sep 30, 2023 | 55.74 Mn |
| Jun 30, 2023 | 48.85 Mn |
| Mar 31, 2023 | 43.63 Mn |
| Dec 31, 2022 | 64.38 Mn |
| Sep 30, 2022 | 47.95 Mn |
| Jun 30, 2022 | 46.78 Mn |
| Mar 31, 2022 | 42.54 Mn |
| Dec 31, 2021 | 49.76 Mn |
| Sep 30, 2021 | 33.26 Mn |